Hwang S-Y, Park S, Kwon Y. Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacol Ther. 2019;199:30–57. https://doi.org/10.1016/j.pharmthera.2019.02.006.
Article CAS PubMed Google Scholar
Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908–31. https://doi.org/10.1016/j.arabjc.2017.05.011.
Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: emerging carriers for drug delivery. Saudi Pharmaceutical Journal. 2011;19(3):129–41. https://doi.org/10.1016/j.jsps.2011.04.001.
Article CAS PubMed PubMed Central Google Scholar
Jain A, Singh SK, Arya SK, Kundu SC, Kapoor S. Protein nanoparticles: promising platforms for drug delivery applications. ACS Biomater Sci Eng. 2018;4(12):3939–61. https://doi.org/10.1021/acsbiomaterials.8b01098.
Article CAS PubMed Google Scholar
Patel S. Emerging trends in nutraceutical applications of whey protein and its derivatives. J Food Sci Technol. 2015;52(11):6847–58. https://doi.org/10.1007/s13197-015-1894-0.
Article CAS PubMed PubMed Central Google Scholar
Souza FN, Gebara C, Ribeiro MCE, Chaves KS, Gigante ML, Grosso CRF. Production and characterization of microparticles containing pectin and whey proteins. Food Res Int. 2012;49(1):560–6. https://doi.org/10.1016/j.foodres.2012.07.041.
Corrochano AR, Buckin V, Kelly PM, Giblin L. Invited review: whey proteins as antioxidants and promoters of cellular antioxidant pathways. J Dairy Sci. 2018;101(6):4747–61. https://doi.org/10.3168/jds.2017-13618.
Article CAS PubMed Google Scholar
Kanoujia J, Singh M, Singh P, Parashar P, Tripathi CB, Arya M, et al. Genipin crosslinked soy-whey based bioactive material for atorvastatin loaded nanoparticles: preparation, characterization and in vivo antihyperlipidemic study. RSC Adv. 2016;6(96):93275–87. https://doi.org/10.1039/C6RA16830B.
Wei Y, Zhan X, Dai L, Zhang L, Mao L, Yuan F, et al. Formation mechanism and environmental stability of whey protein isolate-zein core-shell complex nanoparticles using the pH-shifting method. LWT. 2020;110605.
Giroux HJ, Britten M. Encapsulation of hydrophobic aroma in whey protein nanoparticles. J Microencapsul. 2011;28(5):337–43. https://doi.org/10.3109/02652048.2011.569761.
Article CAS PubMed Google Scholar
Hortobágyi GN. Anthracyclines in the treatment of cancer. An overview Drugs. 1997;54(Suppl 4):1–7. https://doi.org/10.2165/00003495-199700544-00003.
Reddy LH, Murthy R. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly (butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004;148(2):161–6.
Article CAS PubMed Google Scholar
Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L et al. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget. 2016;7(11).
Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620. https://doi.org/10.1007/s13238-020-00789-5.
Article CAS PubMed Google Scholar
Alothaim T, Charbonneau M, Tang X. HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation. Sci Rep. 2021;11(1):10956. https://doi.org/10.1038/s41598-021-90527-6.
Article CAS PubMed PubMed Central Google Scholar
Prajapati R, Garcia-Garrido E, Somoza Á. Albumin-based nanoparticles for the delivery of doxorubicin in breast cancer. Cancers. 2021;13(12):3011.
Article CAS PubMed PubMed Central Google Scholar
Kayani Z, Bordbar A-K, Firuzi O. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells. Biomed Pharmacother. 2018;107:945–56. https://doi.org/10.1016/j.biopha.2018.08.047.
Article CAS PubMed Google Scholar
Morshed RA, Muroski ME, Dai Q, Wegscheid ML, Auffinger B, Yu D, et al. Cell-penetrating peptide-modified gold nanoparticles for the delivery of doxorubicin to brain metastatic breast cancer. Mol Pharm. 2016;13(6):1843–54. https://doi.org/10.1021/acs.molpharmaceut.6b00004.
Article CAS PubMed Google Scholar
Prados J, Melguizo C, Ortiz R, Vélez C, Alvarez PJ, Arias JL, et al. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anticancer Agents Med Chem. 2012;12(9):1058–70. https://doi.org/10.2174/187152012803529646.
Article CAS PubMed Google Scholar
Singh S, Maurya P, Saraf SA. Cutting edge targeting strategies utilizing nanotechnology in breast cancer therapy. Frontiers in Anti-Cancer Drug Discovery 2019;10:180.
Singh S, Singh P, Mishra N, Maurya P, Singh N, Nisha R, et al. Advanced drug delivery systems in breast cancer. Advanced Drug Delivery Systems in the Management of Cancer. Elsevier; 2021;107–26.
Mohamed AI, Abd-Motagaly AME, Ahmed OAA, Amin S, Mohamed Ali AI. Investigation of drug–polymer compatibility using chemometric-assisted UV-spectrophotometry. Pharmaceutics. 2017;9(1):7.
Article PubMed Central Google Scholar
Teng Z, Luo Y, Wang Q. Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation. J Agric Food Chem. 2012;60(10):2712–20. https://doi.org/10.1021/jf205238x.
Article CAS PubMed Google Scholar
Guideline I. Stability testing of new drug substances and products. Q1A (R2), current step. 2003;4:1–24.
Li Y, Angelova A, Hu F, Garamus VM, Peng C, Li N, et al. PH responsiveness of hexosomes and cubosomes for combined delivery of Brucea javanica oil and doxorubicin. Langmuir. 2019;35(45):14532–42.
Article CAS PubMed Google Scholar
Tripathi CB, Parashar P, Arya M, Singh M, Kanoujia J, Kaithwas G, et al. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation. Drug Deliv Transl Res. 2018;8(5):1313–34. https://doi.org/10.1007/s13346-018-0525-5.
Article CAS PubMed Google Scholar
Akbaribazm M, Khazaei MR, Khazaei M. Trifolium pratense L.(red clover) extract and doxorubicin synergistically inhibits proliferation of 4T1 breast cancer in tumor‐bearing BALB/c mice through modulation of apoptosis and increase antioxidant and anti‐inflammatory related pathways. Food Science & Nutrition. 2020;8(8):4276–90.
Kahoush M, Behary N, Cayla A, Mutel B, Guan J, Nierstrasz V. Genipin-mediated immobilization of glucose oxidase enzyme on carbon felt for use as heterogeneous catalyst in sustainable wastewater treatment. J Environ Chem Eng. 2021;9. https://doi.org/10.1016/j.jece.2021.105633
Michel P, Abedinzadeh Z, Grajcar L, Baron M. Spectroscopic study of N-acetylcysteine and N-acetylcystine/hydrogen peroxide complexation. Chem Phys. 1998;228:279–91. https://doi.org/10.1016/S0301-0104(97)00337-6.
Shen H, Gao Q, Ye Q, Yang S, Wu Y, Huang Q, et al. Peritumoral implantation of hydrogel-containing nanoparticles and losartan for enhanced nanoparticle penetration and antitumor effect. Int J Nanomedicine. 2018;13:7409–26. https://doi.org/10.2147/ijn.s178585.
Article CAS PubMed PubMed Central Google Scholar
Tang X, Ding CK, Wu J, Sjol J, Wardell S, Spasojevic I, et al. Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling. Oncogene. 2017;36(30):4235–42. https://doi.org/10.1038/onc.2016.394.
Article CAS PubMed Google Scholar
Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000;20(6c):4785–92.
Kaushik D, Bansal G. Four new degradation products of doxorubicin: an application of forced degradation study and hyphenated chromatographic techniques. Journal of pharmaceutical analysis. 2015;5(5):285–95. https://doi.org/10.1016/j.jpha.2015.05.003.
Article CAS PubMed PubMed Central Google Scholar
Kim A, Ng WB, Bernt W, Cho N-J. Validation of size estimation of nanoparticle tracking analysis on polydisperse macromolecule assembly. Sci Rep. 2019;9(1):2639. https://doi.org/10.1038/s41598-019-38915-x.
Article CAS PubMed PubMed Central Google Scholar
Kanoujia J, Singh M, Singh P, Saraf SA. Novel genipin crosslinked atorvastatin loaded sericin nanoparticles for their enhanced antihyperlipidemic activity. Mater Sci Eng C. 2016;69:967–76. https://doi.org/10.1016/j.msec.2016.08.011.
Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7(1):44735. https://doi.org/10.1038/srep44735.
Article PubMed PubMed Central Google Scholar
Persi E, Duran-Frigola M, Damaghi M, Roush WR, Aloy P, Cleveland JL, et al. Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun. 2018;9(1):2997. https://doi.org/10.1038/s41467-018-05261-x.
Article CAS PubMed PubMed Central Google Scholar
England CG, Miller MC, Kuttan A, Trent JO, Frieboes HB. Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles. Eur J Pharm Biopharm. 2015;92:120–9. https://doi.org/10.1016/j.ejpb.2015.02.017.
Article CAS PubMed PubMed Central Google Scholar
Delneste Y, Jeannin P, Potier L, Romero P, Bonnefoy J-Y. N-acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor α-dependent T-cell cytotoxicity. Blood. 1997;90(3):1124–32. https://doi.org/10.1182/blood.V90.3.1124.
留言 (0)